Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF)
OTC
Closed
Oct 6, 2026
Day's Range
58.7952 wk Range
51.60Overview - RCDTF - Recordati Industria Chimica e Farmaceutica S.p.A.
Key Statistics
Valuation
Enterprise Value
15.75B
P/E (Trailing)
‪21.01‬
Price / Sales (TTM)
‪4.39‬
Price / Book
‪4.86‬
EV / EBITDA
‪13.60‬
Profitability
Gross Margin
‪71.40%‬
Profit Margin
‪18.37%‬
Operating Margin
‪29.19%‬
Return on Assets
‪9.77%‬
Return on Equity
‪24.85%‬
Ownership
Shares Outstanding
204.81M
Float
101.82M
Held by Insiders
‪46.82%‬
Held by Institutions
‪33.09%‬
Price stats
Beta
‪0.53‬
50-Day Avg
‪58.00‬
200-Day Avg
‪59.57‬
Dividends
Payout Ratio
‪56.29%‬
Frequency
Semi-Annual
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - RCDTF - Recordati Industria Chimica e Farmaceutica S.p.A.
Peers - RCDTF - Recordati Industria Chimica e Farmaceutica S.p.A.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on OTC.
Profile Summary - RCDTF - Recordati Industria Chimica e Farmaceutica S.p.A.
About
Recordati Industria Chimica e Farmaceutica S.p.A. is an international pharmaceutical company specializing in the development, manufacturing, and commercialization of innovative medicines across specialty and primary care, consumer healthcare, and rare diseases. Headquartered in Milan, Italy, it traces its origins to a…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
